What are the symptoms of myxedema coma in a patient with hypothyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Myxedema Coma: Clinical Presentation and Symptoms

Myxedema coma is a life-threatening emergency characterized by altered mental status, hypothermia, bradycardia, hypoventilation, and cardiovascular instability in patients with severe, untreated hypothyroidism. 1, 2, 3, 4

Cardinal Clinical Features

Neurological Manifestations

  • Altered mental status ranging from confusion to frank coma is the defining feature 1, 2, 3, 5, 4
  • Mental status changes may progress from lethargy to stupor to complete unresponsiveness 3, 4
  • Absence of brain stem reflexes can occur in severe cases, mimicking brain stem infarction 3
  • Milestone regression may precede altered consciousness in pediatric cases 5

Cardiovascular Symptoms

  • Profound bradycardia is characteristic and slow to respond to initial treatment measures 1, 2
  • Hypotension requiring circulatory support 1, 3
  • Heart block may develop 5
  • Cardiovascular instability with potential for cardiac decompensation 5

Metabolic and Temperature Dysregulation

  • Hypothermia is a hallmark feature, often severe and refractory to warming measures 1, 2, 3, 5
  • Hypoglycemia frequently accompanies the presentation 1
  • Hyponatremia is common 1

Respiratory Manifestations

  • Hypoventilation leading to respiratory failure 1, 3
  • Hypercarbia from inadequate ventilation 5
  • Respiratory support is often required 3

Physical Examination Findings

  • Generalized edema (myxedema) throughout the body 2, 3
  • Nonpitting edema can occur in severe, long-standing cases 6
  • Pericardial effusions may be present 6

Precipitating Factors

Myxedema coma typically occurs when severe, longstanding hypothyroidism is triggered by an acute physiologic stressor. 7, 2, 4

Common Triggers

  • Sepsis and infection are major precipitants 1, 2
  • Surgery represents a critical physiologic stressor 7, 4
  • Trauma or injury can precipitate decompensation 7, 2
  • Cold exposure 2, 4
  • Myocardial infarction 4
  • Cerebrovascular accidents 2
  • Gastrointestinal bleeding 2
  • Sedatives and anesthetics in poorly controlled hypothyroid patients 8, 4
  • Radiation therapy to the neck region for any malignancy 7

Laboratory Abnormalities

  • Severely elevated TSH (e.g., 144.46 mU/L in documented cases) 1
  • Profoundly low free T4 (e.g., 3.4 pmol/L or <0.5 ng/dL) 1, 5
  • Elevated infection markers when sepsis is the trigger 1
  • Acute kidney injury 1
  • Electrolyte derangements including hyponatremia 1

Critical Diagnostic Considerations

The diagnosis is often missed or delayed because patients may present without a known history of hypothyroidism. 2, 3 The condition can mimic other neurological emergencies such as brain stem infarction, making clinical suspicion essential 3.

A high index of clinical suspicion is required when encountering any patient with severe decompensated metabolic state including mental status changes, especially when accompanied by hypothermia. 3 The combination of altered mental status, hypothermia, bradycardia, and hypoventilation in the setting of severe hypothyroidism should immediately raise concern for myxedema coma 5.

Age and Population Considerations

  • More common in older women with hypothyroidism, but can occur at any age 5
  • Can occur in pediatric patients, particularly those with central hypothyroidism 5
  • May present at the time of diagnosis of secondary hypothyroidism, not just with noncompliance in known primary hypothyroidism 5

Urgent Treatment Implications

Treatment must be initiated immediately upon clinical suspicion, even before laboratory confirmation, given the high mortality rate. 4 Intravenous liothyronine and oral levothyroxine should be started emergently 1, and stress doses of intravenous hydrocortisone must be administered simultaneously until adrenal insufficiency is excluded 8, 1, 5, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.